Resultados de la búsqueda 921-930 of 12808 for 搜索引擎在线咨询邮箱：lgooxc@hotmail.com

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...

  3. YouTube - Mayo Clinic Patient Visitor Guide - Arizona - Specialty Building

    Share · Tweet . VID-20164077. Inicio; YouTube - Mayo Clinic Patient Visitor Guide - Arizona - Specialty Building. Tu donación es muy poderosa.

  4. Hematología - Ensayos clínicos

    This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency.

  5. Servicio de consulta de medicina regenerativa de Mayo Clinic

    Share · Tweet . VID-20139414. Inicio; Servicio de consulta de medicina regenerativa de Mayo Clinic. Tu donación es muy poderosa.

  6. Mayo Clinic

    Share · Tweet. March 16, 2019 . VID-20453519. Inicio; Pancreatitis Florida Marketing Video. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

  9. Tendinopatía - Médicos y departamentos - Mayo Clinic

    Tendinopathy research in the departments of Physical Medicine and Rehabilitation (PM&R) and Orthopedic Surgery focus on improving diagnosis and treatment.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...